Normal Saline Flush, 0.9% Injectable Solution: Clinical Trials

3 trials of Normal Saline Flush, 0.9% Injectable Solution, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Terminated 1, Unknown 1

Follow Normal Saline Flush, 0.9% Injectable Solution: new trials by email Literature Review of Normal Saline Flush, 0.9% Injectable Solution trials Research Report on Normal Saline Flush, 0.9% Injectable Solution

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study of Intranasal Lidocaine in Acute Management of Pediatric Migraine
Lidocaine 2% Injectable Solution, Normal Saline Flush, 0.9% Injectable Solution - Migraine in Children, Posttraumatic Headache
Phase 1CompletedUniversity of British Columbia302019-07-032021-04-28
The Erector Spinae Plane Block and Its Effect on Respiratory Status and Pain Management in Rib Fracture Patients
Ropivacaine, Normal Saline Flush, 0.9% Injectable Solution - Rib Fractures
Phase 1TerminatedVirginia Commonwealth University42019-05-242020-08-07
Low-dose Ketamine for Acute Pain in the Emergency Department
Ketamine, Placebos, Morphine - Pain
Phase 1UnknownFaculty of Medicine, Sousse1252016-01-012017-01-31

Conditions studied

Agnosia (1)  ·  Emergencies (1)  ·  Pain (1)  ·  Post-Traumatic Headache (1)  ·  Rib Fractures (1)

Sponsors

Faculty of Medicine, Sousse (1)  ·  University of British Columbia (1)  ·  Virginia Commonwealth University (1)

Countries

Canada (1)  ·  Tunisia (1)  ·  United States (1)

Top investigators

Bryant Tran, MD (1)  ·  Garth Meckler, MD (1)